lumiracoxib
(KHPKQFYUPIUARC-UHFFFAOYSA-N)
Structure
- SMILES
- OC(=O)Cc1cc(C)ccc1Nc1c(F)cccc1Cl
- Type(s)
- Approved; Investigational
- ATC code(s)
- M01AH06
- Molecular Formula:
- C15H13ClFNO2
- Molecular Weight:
- 293.721
- Log P:
- 4.2312
- Hydrogen Bond Acceptor:
- 2
- Hydrogen Bond Donor:
- 2
- TPSA:
- 49.33
- CAS Number(s):
- 220991-20-8
Synonym(s)
1.
lumiracoxib
2.
COX 189
3.
COX-189
4.
prexige
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Abdominal Pain | Canada Vigilance: 1 | 17478464 | CTD Canada Vigilance |
| 2 | Abdominal discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 3 | Amnesia | Canada Vigilance: 1 | Canada Vigilance | |
| 4 | Anaphylactoid Reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 5 | Asthma | Canada Vigilance: 1 | Canada Vigilance | |
| 6 | Back Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 7 | Blood cholesterol increased | Canada Vigilance: 1 | Canada Vigilance | |
| 8 | Blood creatinine increased | Canada Vigilance: 1 | Canada Vigilance | |
| 9 | Bradycardia | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | Burning sensation | Canada Vigilance: 1 | Canada Vigilance | |
| 11 | Cerebrovascular accident | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Chemical and Drug Induced Liver Injury | CTD | ||
| 13 | Chest Pain | Canada Vigilance: 2 | Canada Vigilance | |
| 14 | Chest discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | Cholelithiasis | Canada Vigilance: 1 | Canada Vigilance | |
| 16 | Disorientation | Canada Vigilance: 1 | Canada Vigilance | |
| 17 | Dizziness | Canada Vigilance: 4 | Canada Vigilance | |
| 18 | Drug ineffective | Canada Vigilance: 15 | Canada Vigilance | |
| 19 | Dysmenorrhea | 17661736 | CTD | |
| 20 | Gout | 17478464 | CTD | |
| 21 | Headache | 17478464 | CTD | |
| 22 | Hepatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 23 | Hepatomegaly | Canada Vigilance: 1 | Canada Vigilance | |
| 24 | Hepatotoxicity | Canada Vigilance: 1 | Canada Vigilance | |
| 25 | Hyperacusis | Canada Vigilance: 1 | Canada Vigilance | |
| 26 | Joint stiffness | Canada Vigilance: 1 | Canada Vigilance | |
| 27 | Low density lipoprotein increased | Canada Vigilance: 1 | Canada Vigilance | |
| 28 | Memory impairment | Canada Vigilance: 1 | Canada Vigilance | |
| 29 | Menorrhagia | Canada Vigilance: 1 | Canada Vigilance | |
| 30 | Metrorrhagia | Canada Vigilance: 1 | Canada Vigilance | |
| 31 | Myocardial Infarction | 17457957 | CTD | |
| 32 | Nausea | Canada Vigilance: 4 | 17478464 | CTD Canada Vigilance |
| 33 | Pain, Postoperative | 17661736 | CTD | |
| 34 | Pain | Canada Vigilance: 1 | 20639878 | CTD Canada Vigilance |
| 35 | Palpitations | Canada Vigilance: 2 | Canada Vigilance | |
| 36 | Pruritus | Canada Vigilance: 2 | Canada Vigilance | |
| 37 | Takotsubo Cardiomyopathy | 18092115 | CTD | |
| 38 | Urticaria | Canada Vigilance: 1 | Canada Vigilance | |
| 39 | Vomiting | Canada Vigilance: 1 | Canada Vigilance | |
| 40 | jaundice | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.